ALTERNATIVE FINANCING FORMS
FOR ENTREPRENEURS AND INVESTORS
News

Themis Beteiligungs AG sells shares in Dermapharm

Cate­gory: Private Equity
Photo: Simon Weiß, Part­ner at McDer­mott Will & Emery (Frank­furt)
21. Octo­ber 2020

Frank­furt — McDer­mott Will & Emery advi­ses Joh. Beren­berg, Goss­ler & Co. KG (Beren­berg) as Sole Global Coor­di­na­tor and Sole Book­run­ner on the sale of shares in Derm­a­ph­arm Holding SE by Themis Betei­­li­­gungs-Akti­en­­ge­­sel­l­­schaft. The tran­sac­tion volume amounts to appro­xi­m­ately EUR 250 million.

Derm­a­ph­arm is a leading manu­fac­tu­rer of off-patent bran­ded phar­maceu­ti­cals for selec­ted markets in Germany.

The McDer­mott team led by part­ners Simon Weiß and Joseph W. Marx regu­larly advi­ses Beren­berg on capi­tal market tran­sac­tions, most recently on the capi­tal increase of CORESTATE Capi­tal Holding S.A. and the capi­tal measure of CompuGroup Medi­cal SE & Co. KGaA.

Advi­sor Beren­berg: McDer­mott Will & Emery (Frank­furt)
Simon Weiß (Capi­tal Markets) and Joseph W. Marx (US Capi­tal Markets, both Lead), Andrea Adele Stock­horst (Finan­cial Regu­la­tory); Asso­ciate: Isabelle Müller (Corpo­rate)

Inhouse Beren­berg: Dr. Martin Knie­hase (Head of Invest­ment Banking Legal Conti­nen­tal Europe, Direc­tor) and Vanessa Harms, LL.M. (Asso­ciate Direc­tor, Invest­ment Banking Legal)

About McDer­mott Will & Emery
McDer­mott Will & Emery Attor­neys Tax LLP is a leading inter­na­tio­nal law firm. With over 1,200 attor­neys, we are repre­sen­ted in 20 loca­ti­ons world­wide: Atlanta, Boston, Brussels, Chicago, Dallas, Düssel­dorf, Frank­furt a.M., Hous­ton, London, Los Ange­les, Miami, Milan, Munich, New York, Orange County, Paris, San Fran­cisco, Sili­con Valley, Washing­ton, D.C. and Wilm­ing­ton. The German prac­tice is mana­ged by McDer­mott Will & Emery Rechts­an­wälte Steu­er­be­ra­ter LLP. www.mwe.com

Subscribe newsletter

Here you can read about the latest transactions, IPOs, private equity deals and venture capital investments, who has raised a new fund, how Buy & Build activities are going.

Get in touch

Contact us!
fyb [at] fyb.de